Sanofi, Access Industries and Alphabet helped Areteia Therapeutics raise $350m, and Nordisk Games acquires Supermassive Games.
Funding
US-based asthma therapy developer Areteia Therapeutics has raised $350m from investors including pharmaceutical firm Sanofi, internet and technology group Alphabet’s GV subsidiary and Access Biotechnology, part of conglomerate Access Industries. The round was led by private equity firm Bain Capital through its Bain Capital Life Sciences fund, while Arch Venture Partners, Saturn Partners, Maverick Capital and private equity firm Population Health Partners also took part. Areteia was formed by Population Health Partners and drug developer Knopp Biosciences.
…
